SOW
MRTX

State of Wyoming’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

State of Wyoming’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-120
Closed -$8K – 2042
2022
Q2 		$8K Buy
120
+29
+32% +$1.84K 0.01% 1680
2022
Q1 		$7K Buy
91
+15
+20% +$1.53K ﹤0.01% 1644
2021
Q4 		$11K Sell
76
-4
-5% -$621 0.01% 1661
2021
Q3 		$14K Sell
80
-39
-33% -$6.27K 0.01% 989
2021
Q2 		$19K Buy
119
+63
+113% +$10.1K 0.01% 939
2021
Q1 		$10K Buy
+56
New +$11.1K 0.02% 392

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State of Wyoming's MRTX Position: Q3 2022 in Review

State of Wyoming sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 120 shares — an estimated $8K sold.

State of Wyoming first reported a position in MRTX in Q1 2021 and held it in 6 quarters. The position peaked at $19K in Q2 2021. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

  • State of Wyoming reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 120 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $8K.
  • State of Wyoming first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Mirati Therapeutics, Inc. Common Stock position peaked at $19K in Q2 2021.
  • 243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.